Tanaka R - Search Results

1

Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.

Ishiko S, Horinouchi T, Fujimaru R, Shima Y, Kaito H, Tanaka R, Ishimori S, Kondo A, Nagai S, Aoto Y, Sakakibara N, Nagano C, Yamamura T, Yoshimura M, Nakanishi K, Fujimura J, Kamiyoshi N, Nagase H, Yoshikawa N, Iijima K, Nozu K. Ishiko S, et al. Among authors: tanaka r. Sci Rep. 2020 Aug 20;10(1):14026. doi: 10.1038/s41598-020-71101-y. Sci Rep. 2020. PMID: 32820208 Free PMC article.

2

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome.

Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa N. Iijima K, et al. Among authors: tanaka r. Kidney Int. 2002 May;61(5):1801-5. doi: 10.1046/j.1523-1755.2002.00303.x. Kidney Int. 2002. PMID: 11967030 Free article. Clinical Trial.

3

Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.

Zhou A, Ueno H, Shimomura M, Tanaka R, Shirakawa T, Nakamura H, Matsuo M, Iijima K. Zhou A, et al. Among authors: tanaka r. Kidney Int. 2003 Jul;64(1):92-101. doi: 10.1046/j.1523-1755.2003.00045.x. Kidney Int. 2003. PMID: 12787399 Free article.

4

A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy.

Nakanishi K, Sako M, Yata N, Aoyagi N, Nozu K, Tanaka R, Iijima K, Yoshikawa N. Nakanishi K, et al. Among authors: tanaka r. Pediatr Nephrol. 2004 Feb;19(2):144-7. doi: 10.1007/s00467-003-1350-7. Epub 2003 Nov 28. Pediatr Nephrol. 2004. PMID: 14648325

5

Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome.

Fu XJ, Iijima K, Nozu K, Hamahira K, Tanaka R, Oda T, Yoshikawa N, Matsuo M. Fu XJ, et al. Among authors: tanaka r. Pediatr Nephrol. 2004 Aug;19(8):844-52. doi: 10.1007/s00467-004-1502-4. Epub 2004 Jun 17. Pediatr Nephrol. 2004. PMID: 15206036

6

Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?

Fujita T, Nozu K, Iijima K, Kamioka I, Yoshiya K, Tanaka R, Hamahira K, Nakanishi K, Yoshikawa N, Matsuo M. Fujita T, et al. Among authors: tanaka r. Pediatr Nephrol. 2006 Feb;21(2):194-200. doi: 10.1007/s00467-005-2074-7. Epub 2005 Oct 25. Pediatr Nephrol. 2006. PMID: 16247645

7

High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.

Nozu K, Iijima K, Kamioka I, Fujita T, Yoshiya K, Tanaka R, Nakanishi K, Yoshikawa N, Matsuo M. Nozu K, et al. Among authors: tanaka r. Pediatr Int. 2006 Apr;48(2):152-7. doi: 10.1111/j.1442-200X.2006.02178.x. Pediatr Int. 2006. PMID: 16635174

8

OCRL1 mutations in patients with Dent disease phenotype in Japan.

Sekine T, Nozu K, Iyengar R, Fu XJ, Matsuo M, Tanaka R, Iijima K, Matsui E, Harita Y, Inatomi J, Igarashi T. Sekine T, et al. Among authors: tanaka r. Pediatr Nephrol. 2007 Jul;22(7):975-80. doi: 10.1007/s00467-007-0454-x. Epub 2007 Mar 24. Pediatr Nephrol. 2007. PMID: 17384968

9

Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.

Kamioka I, Nozu K, Fujita T, Kaito H, Tanaka R, Yoshiya K, Iijima K, Nakanishi K, Yoshikawa N, Matsuo M. Kamioka I, et al. Among authors: tanaka r. Pediatr Int. 2007 Apr;49(2):196-201. doi: 10.1111/j.1442-200X.2007.02352.x. Pediatr Int. 2007. PMID: 17445038

10

Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG).

Fujita T, Nozu K, Iijima K, Kamioka I, Kaito H, Tanaka R, Nakanishi K, Matsuo M, Yoshikawa N. Fujita T, et al. Among authors: tanaka r. Pediatr Nephrol. 2007 Nov;22(11):1957-61. doi: 10.1007/s00467-007-0555-6. Epub 2007 Aug 3. Pediatr Nephrol. 2007. PMID: 17674054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,463 results

Search Page